Lorlatinib API is a third-generation ALK and ROS1 tyrosine kinase inhibitor used in the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC).

Lorlatinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.